FindTrial
Sign In

"EFFECT OF NAYANSUKHAVARTI ANJANA IN THE MANAGEMENT OF PROGRESSIVE PTERYGIUM:"

"EFFECT OF NAYANSUKHAVARTI ANJANA COMPARED WITH CHANDRODAYAVARTI ANJANA IN THE MANAGEMENT OF PRASTARI ARMA WITH SPECIAL REFERENCE TO PROGRESSIVE PTERYGIUM: A RANDOMIZED CONTROLLED TRIAL"

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038432
Enrollment
84
Registered
2021-12-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H110- Pterygium of eye

Interventions

None listed

Sponsors

SHRI AYURVED MAHAVIDYALAYA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 PATIENTS HAVING LAKSHANAS OF PRASTARI ARMA LIKE MAMSVRIDDHI UPTO LIMBUS AND LESS THAN LIMBUS RAGA NETRASTRAVE TODA AVILDARSHAN 2 PATIENTS WILLING AND ABLE TO PARTICIPATE FOR 1 MONTH OF TREATMENT

Exclusion criteria

Exclusion criteria: 1 PATIENTS HAVING ARMA INDICATED FOR SURGERY ENCROACHING ON CORNEA MORE THAN LIMBAL MARGIN 2 PATIENTS HAVING MAJOR AND COMPLICATED SYSTEMIC DISEASES LIKE DM HTN AND OTHER EYE DISEASES 3 PATIENTS OF CORNEAL ULCER ,MALIGNANT EYE CONDITION DACROCYSTITIS

Design outcomes

Primary

MeasureTime frame
A COMPARATIVE CLINICAL STUDY TO EVALUATE EFFICACY OF NAYANSUKHAVARTI ANJANA AND CHANDRODAYAVARTI ANJANA IN PRASTARI ARMATimepoint: THE DRUG WILL BE GIVEN 30 DAYS THE PATIENT WILL ASSESSED BEFORE AND AFTER TREATMENT TOTAL DURATION OF STUDY WILL BE 18 MONTHS—

Secondary

MeasureTime frame
TO COMPARE THE LEVEL OF TODA RAGA NETRASTRAV AVILDARSHAN IN THE PATIENTS OF PRASTARI ARMA IN BOTH GROUPSTimepoint: 0TH 7TH 15TH 30TH DAY—

Countries

India

Contacts

Public ContactVd MOHAN BHAURAOJI YEOLE

SHRI AYURVED MAHAVIDYALAYA

mohanyeole@gmail.com9423935631

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026